Zacks Investment Research cut shares of Exactech Inc. (NASDAQ:EXAC) from a hold rating to a sell rating in a report released on Thursday morning.
According to Zacks, “Exactech, Inc. develops, manufactures, markets and distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its principal products include its knee and hip replacement systems. Exactech, Inc. is headquartered in Gainesville, Florida. “
Exactech (NASDAQ:EXAC) traded up 3.97% during midday trading on Thursday, reaching $23.55.
